title: Staphylococcus pseudintermedius exfoliative toxin EXI selectively digests canine desmoglein 1 and causes subcorneal clefts in canine epidermis.
abstract: Staphylococcal exfoliative toxins are known to digest desmoglein (Dsg) 1, a desmosomal cell-cell adhesion molecule, thus causing intraepidermal splitting in human bullous impetigo, staphylococcal scalded skin syndrome and swine exudative epidermitis. Recently, a novel exfoliative toxin gene (exi), whose sequence shares significant homology with previously identified exfoliative toxins, was isolated from Staphylococcus pseudintermedius. Little is known about the pathogenic involvement of this toxin in canine pustular diseases such as impetigo. The aim of this study was to determine whether EXI, the product of the exi gene, digests canine Dsg1 and causes intraepidermal splitting in canine skin. An exi gene was isolated from chromosomal DNA of an S. pseudintermedius strain obtained from a pustule of a dog with impetigo, and was used to produce a recombinant EXI by Escherichia coli expression. When purified recombinant EXI was injected intradermally into normal dogs, it caused the development of vesicles or erosions with superficial epidermal splitting. In addition, the EXI abolished immunofluorescence for Dsg1, but not for Dsg3, at the injection sites. Moreover, the EXI directly degraded baculovirus-secreted recombinant extracellular domains of canine Dsg1, but not that of canine Dsg3, in vitro. The EXI also degraded mouse Dsg1α and swine Dsg1, but not human Dsg1, mouse Dsg1β and Dsg1γ. Conversely, recombinant SIET, previously designated as S. intermedius exfoliative toxin, did not cause intraepidermal splitting or degradation of any Dsgs. These findings indicate that EXI has a proteolytic activity that digests canine Dsg1, and this characteristic might be involved in the pathogenesis of intraepidermal splitting in canine impetigo.
authors.affiliation: Laboratory of Veterinary Internal Medicine, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan.
authors.forename: Keita
authors.initials: K
authors.lastname: Iyori
authors.forename: Keiko
authors.initials: K
authors.lastname: Futagawa-Saito
authors.forename: Junzo
authors.initials: J
authors.lastname: Hisatsune
authors.forename: Masahiko
authors.initials: M
authors.lastname: Yamamoto
authors.forename: Maiko
authors.initials: M
authors.lastname: Sekiguchi
authors.forename: Kaori
authors.initials: K
authors.lastname: Ide
authors.forename: Won-Geun
authors.initials: WG
authors.lastname: Son
authors.forename: Thierry
authors.initials: T
authors.lastname: Olivry
authors.forename: Motoyuki
authors.initials: M
authors.lastname: Sugai
authors.forename: Tsuguaki
authors.initials: T
authors.lastname: Fukuyasu
authors.forename: Toshiroh
authors.initials: T
authors.lastname: Iwasaki
authors.forename: Koji
authors.initials: K
authors.lastname: Nishifuji
mesh_terms: D000818:Animals; D051183:Desmoglein 1 / Q000378:metabolism*; D004283:Dog Diseases / Q000139:chemically induced*; D004285:Dogs; D003875:Drug Eruptions / Q000662:veterinary*; D004817:Epidermis / Q000187:drug effects*; D005083:Exfoliatins / Q000378:metabolism / Q000633:toxicity*; D015964:Gene Expression Regulation, Bacterial; D051379:Mice; D011994:Recombinant Proteins / Q000378:metabolism; D013210:Staphylococcus / Q000145:classification / Q000378:metabolism*
chemical_list: D051183:Desmoglein 1; D005083:Exfoliatins; D011994:Recombinant Proteins